Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B

Abnormal alternative splicing (AS) caused by alterations to splicing factors contributes to tumor progression. Serine/arginine splicing factor 1 (SRSF1) has emerged as a key oncodriver in numerous solid tumors, leaving its roles and mechanisms largely obscure in glioma. Here, we demonstrate that SRS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Zhou, Xuexia, Wang, Run, Li, Xuebing, Yu, Lin, Hua, Dan, Sun, Cuiyun, Shi, Cuijuan, Luo, Wenjun, Rao, Chun, Jiang, Zhendong, Feng, Ying, Wang, Qian, Yu, Shizhu
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355305/
https://ncbi.nlm.nih.gov/pubmed/30481162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI120279
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars